Clearmind Medicine Inc (NASDAQ:CMND)’s traded shares stood at 38.92 million during the latest session, with the company’s beta value hitting -1.29. At the last check today, the stock’s price was $1.0, to imply an increase of 10.85% or $0.1 in intraday trading. The CMND share’s 52-week high remains $2.30, putting it -130.0% down since that peak but still an impressive 20.0% since price per share fell to its 52-week low of $0.80. The company has a valuation of $5.39M, with an average of 53590.0 shares in intraday trading volume over the past 10 days and average of 250.08K shares over the past 3 months.

Clearmind Medicine Inc (NASDAQ:CMND) trade information

After registering a 10.85% upside in the latest session, Clearmind Medicine Inc (CMND) has traded red over the past five days. The 5-day price performance for the stock is 13.54%, and 6.09% over 30 days. With these gigs, the year-to-date price performance is -39.70%. Short interest in Clearmind Medicine Inc (NASDAQ:CMND) saw shorts transact 0.12 million shares and set a 1.04 days time to cover.

CMND Dividends

Clearmind Medicine Inc has its next earnings report out in August. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.

Clearmind Medicine Inc (NASDAQ:CMND)’s Major holders

Clearmind Medicine Inc insiders hold 2.80% of total outstanding shares, with institutional holders owning 11.19% of the shares at 11.51% float percentage. In total, 11.19% institutions holds shares in the company.

Going by data provided on May 31, 2025 , AdvisorShares Trust-AdvisorShares Psychedelics ETF holds roughly 205.93 shares. This is just over 4.83% of the total shares, with a market valuation of $0.21 million